TNF and rheumatoid arthritis: Biologics targeting proteins such as TNFα for rheumatoid arthritis and IL-17 for psoriasis are prime examples of how knowledge about key nodal points mediating disease mechanisms can lead to therapies that change treatment paradigms for patients.